The Oncology Institute Announces Resignation of Board Member Gabe Ling

Core Points - Gabe Ling has resigned from the Board of Directors of The Oncology Institute, effective December 1, 2025, and a search for new independent directors with relevant expertise has begun [1] - The Chairman of the Board, Anne McGeorge, expressed gratitude for Gabe Ling's contributions during a significant period for the company and emphasized the focus on enhancing the Board's capabilities for long-term growth [2] - The Oncology Institute, founded in 2007, provides specialized, value-based cancer care to approximately 1.9 million patients through over 100 clinics and affiliate locations across five states [3]